SavedAdd your journal

Journals / Türkiye Çocuk Hastalıkları Dergisi / 2015 / Cilt: 9 - Sayı: 3

The Experinences of Muğla City in Prevention of Thalassemia

Beta Talasemi̇ ile Mücadelede Muğla Deneyi̇mleri̇

Can Naci KOCABAŞ
Mustafa Nuri CEYHAN
Fatih Mehmet AZIK
Hatice TOPAL
Yaşar TOPAL
Pages
226–229
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In Mugla, which is one of the places where thalassemia is frequentlyseen, occured a significant reduction in the number of cases, through regularly conducted screening programs.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:As one of the most common genetically inherited diseases in the world, beta thalassemia continues to be a major healthproblem in our country, too.
📊
Key Findings & Data:In our country, the carrier rate is around 2%.
💡
Conclusion & Impact:In Mugla, which is one of the places where thalassemia is frequentlyseen, occured a significant reduction in the number of cases, through regularly conducted screening programs.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

As one of the most common genetically inherited diseases in the world, beta thalassemia continues to be a major healthproblem in our country, too. In our country, the carrier rate is around 2%. The carriers appearance is usually normal andthis reveals the necessity of screening programs. In Mugla, which is one of the places where thalassemia is frequentlyseen, occured a significant reduction in the number of cases, through regularly conducted screening programs.

Özet

Dünyada en sık görülen genetik geçişli hastalıklardan biri olan beta talasemi, ülkemizde de önemli bir sağlık sorunu olmayadevam etmektedir. Ülkemizde beta talasemi taşıyıcılık oranı %2 civarındadır. Taşıyıcı olanların genellikle normal görünümdeolmaları tarama programlarının gerekliliğini ortaya koymaktadır. Beta talaseminin sık görüldüğü yerlerden biri olan Muğladadüzenli yapılan tarama programları sayesinde yeni hasta olguların sayısında da önemli derecede azalma olmuştur.

🔖

Cite This Article

KOCABAŞ, C. N., CEYHAN, M. N., AZIK, F. M., TOPAL, H., TOPAL, Y. (2022). The Experinences of Muğla City in Prevention of Thalassemia. Türkiye Çocuk Hastalıkları Dergisi, Cilt: 9 - Sayı: 3, 226–229. https://ajindex.com/articles/627465

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Cao A, Galanello R. Beta-thalassemia. Genet Med 2010;12:61-76
  2. Guler E, Caliskan U, Albayrak C, Karacan M. Prevalence of beta- thalassemia and sickle cell anemia trait in premarital screening in Konya urban area, Turkey. J Pediatr Hematol Oncol 2007;29: 783-5
  3. Wheatherall DJ, Clegg JB. The thalassemia syndromes. 4th ed. Oxford: Blackwell Science Ltd, 2001
  4. Weatherall DJ, Clegg JB, Higgs DR, Wood WG. The hemoglobinopathies. In:Scriver CR, Beaudet Al, Sly WS, Valle D, Vogelstein B (eds). The Meta-bolic and Molecular Bases of Inherited Disease (OMMBID). New York: McGraw-Hill, 2002. Available at: www.ommbid.com. Accessed December 31, 2007 5. Canatan D, Köse MR, Üstündağ M, Haznedaroğlu M, Özbaş S. Hemoglobinopathy Control Program in Turkey. Community Genet 2006;9:124-6
  5. Altay Ç. Abnormal hemoglobins in Turkey. Turk J Haematol 2002;19:63-74
  6. Ministry of Health. Mother and child health general director. Hemoglobinopathy control program. Editor: Canatan D. J Hematol Oncol Special Topics 2010;3:5-8 8. Cao A, Pirastu M, Rosatelli MC. The prenatal diagnosis of thalassaemia. Br J Haematol 1986;63:215-20
  7. Bozkurt G. Thalassemia prevention and control program in the Turkish Republic of Northern Cyprus. In: Bozkurt G (ed). 2nd. International Thalassemia Summer School. KKTC:Girne, 2002: 41
  8. Bozkurt G. Results from the North Cyprus thalassemia prevention program. Hemoglobin 2007;31:257-64
  9. Amato A, Grisanti P, Lerone M, Ponzini D, Di Biagio P, Cappabianca MP, et al. Prevention strategies for severe hemoglobinopathies in endemic and nonendemic immigration countries: The Latium example. Prenat Diagn 2009;29:1171-4
  10. Silvestroni E, Bianco I. Screening for microcytemia in Italy: Analysis of data collected in the past 30 years. Am J Hum Genet 1975;27:198-212
  11. Çavdar AO, Arcasoy A. The incidence of beta-thalassemia and abnornal hemoglobins in Turkey. Acta Hematol 1971;45:313-8
  12. Akar N, Çavdar AO, Dessi E, Loi A, Pirastu M,Cao A. Thalassemia mutations in Turkish populations. J Med Genet 1987;24:378-9